SEC Form 4 · accession 0000874015-15-000058
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederick T Muto
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2015 | M | 10,000 | $3.95 | A | 11,095 | D | |
| Common StockF1 | Jun 1, 2015 | S | 10,000 | $66.911 | D | 1,095 | D | |
| Common Stock | holding | — | — | — | 1,500 | I | By Cooley Godward Kronish LLP Sal Def & PSP U/A DTD 2/1/74 Pension Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director stock option (right to buy) | $3.95 | Jun 1, 2015 | M | 10,000 | D | Jul 1, 2009 | Jun 30, 2015 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2015. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 5/5/2013.